TABLE 5.

Observed Means, Standard Deviations, and Effect sizes for Primary and Secondary Outcome Measures at Pre, Post, and Follow-up.

		All participants				5-day group				3-day group
Measure	Assessment	n	M	SD	ES pre-postw pre-FUw	n	M	SD	ES pre-postw pre-FUw	n	M	SD	ES pre-postw pre-FUw
PHQ	Pre	82	9.23	3.08		38	9.53	3.25		44	8.98	2.95
	Post	43	7.65	4.11	0.51	16	7.06	3.00	0.76	27	8.00	4.66	0.33
	Follow up	42	8.40	5.59	0.27	17	8.06	5.49	0.45	25	8.64	5.75	0.12
GAD	Pre	82	9.40	3.95		38	9.63	3.40		44	9.20	4.39
	Post	43	6.23	4.04	0.80	16	5.75	3.80	1.14	27	6.52	4.22	0.61
	Follow up	42	7.67	4.76	0.44	17	7.94	4.51	0.50	25	7.48	5.01	0.39
PANAS	Pre	82	15.00	3.55		38	15.00	3.58		44	15.00	3.57
Pos	Post	42	15.86	3.43	0.24	16	16.56	3.39	-0.44	26	15.42	3.45	0.12
	Follow up	41	16.29	4.27	0.36	16	17.31	4.47	-0.65	25	15.64	4.10	0.18
PANAS	Pre	82	14.16	3.71		38	14.16	3.18		44	14.16	4.15
Neg	Post	42	11.43	3.56	0.74	16	11.38	3.30	0.87	26	11.46	3.77	0.65
	Follow up	41	11.34	4.07	0.76	16	12.06	4.42	0.66	25	10.88	3.85	0.79

ES = Within-group Effect Size; FU = Follow-up; PHQ = Patient Health Questionnaire; GAD = General Anxiety Disorder; PANAS-Pos = Positive Emotion Subscale from the Positive and Negative Affect Schedule; PANAS-Neg = Negative Emotion Subscale from the Positive and Negative Affect Schedule.